Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High-Volume Microplate Designed for Sensitive Photometric Assays

By LabMedica International staff writers
Posted on 02 Dec 2009
With a well volume of 3.1 mL, a new microplate is a suitable choice for screening applications that require high sensitivity combined with photometric accuracy and repeatability. More...
Moreover, the microplate's large surface area per well makes the tissue culture-treated version of the plate ideal for cell growth applications.

Constructed in ultra-pure grade polystyrene, Krystal 24 microplates, developed by Porvair Sciences, Ltd. (Leatherhead, Surrey UK), are available in opaque white and solid black formats. For sensitive fluorescence measurements, the black plate provides the all-absorbing background needed to minimize background interference. The opaque white plate maximizes reflectivity enabling even weakly emitting luminescence assays to be routinely undertaken. In addition to optimized luminescence and fluorescence measurements, the unique Krystal 24 design offers improved cell binding efficiency and provides the convenience of direct measurements on bottom reading spectrophotometers and inverted microscopes.

Precisely manufactured to SBS/ANSI microplate dimensions, the cost-effective Krystal 24 design is fully compatible with all commercially available plate readers, robotic sample processors, and automated liquid-handling systems. (ANSI/SBS 1-2004 Microplate Footprint Dimensions as registered and designated by the American National Standards Institute [ANSI]).

Porvair Sciences' expertise in microplate technology and manufacturing covers scientific fields including life sciences, drug discovery, combinatorial chemistry, solid phase extraction, protein purification, high-throughput screening, proteomics and genomics. Porvair Sciences is a wholly owned subsidiary of Porvair plc.

Related Links:
Porvair Sciences



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.